The Food and Drug Administration is moving forward in the creation of a regulatory approval pathway for follow-on biologics and is requesting input from stakeholders and the public, the agency said Monday.
Drug maker Merck announced that it has kicked off an initiative that includes a wide range of public education and patient support programs, as well as research efforts to help improve care for people living with chronic hepatitis C virus infections.
The Council for Responsible Nutrition earlier this week announced the launch of a microsite as part of its joint education campaign with the American Academy of Nurse Practitioners and the American Academy of Nurse Practitioners Foundation.
The number of people diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new Vital Signs report released earlier this week by the Centers for Disease Control and Prevention.
Akorn, a niche generic pharmaceutical company, earlier this week entered into an agreement to acquire Advanced Vision Research, an over-the-counter ophthalmic company that promotes eye care products under the TheraTears and MacuTrition brands.
The blood test recommended for detecting Type 2 diabetes in overweight children may not be enough, and they may need two different tests to diagnose the disease, according to research conducted at Children's Mercy Hospital and Clinics in Kansas City, Mo.
FlavoRx and Rochester Drug Cooperative on Thursday announced a long-term distribution agreement designed to bring the FlavoRx brand to more than 950 independent pharmacies serviced by RDC throughout New York, New Jersey, Pennsylvania, Ohio and Connecticut.
A major depressive disorder treatment made by Pfizer significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women, compared with placebo, according to a new study.